Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 29, 2021 Filed Jan 28, 2022 16:33 UTC |
SALERNO FREDERIC VDirector
|
GiftCommon Stock | 1,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-005420 · doc5.xml · nonDerivative · entry 1 SALERNO FREDERIC V · CIK 0001180138 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,948 F1 · shares: The transaction involved a gift of 1,880 shares of the Issuer's common stock by the reporting person to a private foundation. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 9,227 shares of common stock and 1,721 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 21:08 UTC |
Martin Lynn CPresident, Fixed Income & Data
|
SaleCommon Stock | 2,500 | $131.00 | $327,500.00 |
DisclosureSEC source: 0001209191-21-061169 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, Fixed Income & Data 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,389 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 20,114 shares of common stock and 12,275 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| October 08, 2021 Filed Oct 12, 2021 16:32 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 2,000 | $126.74 | $253,480.00 |
DisclosureSEC source: 0001209191-21-060234 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,918 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 12,451 shares of common stock and 9,467 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 20:31 UTC |
Martin Lynn CPresident, Fixed Income & Data
|
SaleCommon Stock | 2,500 | $125.00 | $312,500.00 |
DisclosureSEC source: 0001209191-21-060232 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, Fixed Income & Data 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,889 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2021. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 22,614 shares of common stock and 12,275 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 52,582 | $0.00 Strike: $25.87 | $0.00 |
DisclosureSEC source: 0001209191-21-057631 · doc4.xml · derivative · entry 9 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,582 shares Expires 2023-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options are fully vested. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 36,955 | $0.00 Strike: $22.43 | $0.00 |
DisclosureSEC source: 0001209191-21-057631 · doc4.xml · derivative · entry 8 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,955 shares Expires 2022-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options are fully vested. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 100 | $117.52 | $11,752.00 |
DisclosureSEC source: 0001209191-21-057631 · doc4.xml · nonDerivative · entry 6 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,091,705 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F7 · balance_after: These shares are beneficially owned directly by Continental Power Exchange, Inc. ("CPEX"). Mr. Sprecher beneficially owns 100% of the equity interest in CPEX directly. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 59,900 | $117.03 | $7,010,336.60 |
DisclosureSEC source: 0001209191-21-057631 · doc4.xml · nonDerivative · entry 5 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,091,805 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F6 · price: The price range for the aggregate amount sold by the direct holder is $116.52 - $117.51. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 357 | $117.52 | $41,955.21 |
DisclosureSEC source: 0001209191-21-057631 · doc4.xml · nonDerivative · entry 4 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,326,500 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $117.52 - $117.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,254,988 shares of common stock and 71,512 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 108,680 | $117.03 | $12,718,472.62 |
DisclosureSEC source: 0001209191-21-057631 · doc4.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,326,857 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $116.52 - $117.51. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 52,582 | $25.87 | $1,360,296.34 |
DisclosureSEC source: 0001209191-21-057631 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,435,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 36,955 | $22.43 | $828,900.65 |
DisclosureSEC source: 0001209191-21-057631 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,382,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2021. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 20:31 UTC |
Silver Caroline LouiseDirector
|
Tax withholdingCommon Stock | 137 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-057038 · doc4.xml · nonDerivative · entry 1 Silver Caroline Louise · CIK 0001821735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,904 F1 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 1,963 shares of common stock and 1,941 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 16:31 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 2,000 | $120.00 | $240,000.00 |
DisclosureSEC source: 0001209191-21-055925 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,918 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 14,451 shares of common stock and 9,467 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:33 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 1,758 | $117.48 | $206,529.84 |
DisclosureSEC source: 0001209191-21-053629 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,579 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2021. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 31,928 shares of common stock and 6,651 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 16:38 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 2,000 | $120.22 | $240,440.00 |
DisclosureSEC source: 0001209191-21-051121 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,918 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2021. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 16,451 shares of common stock and 9,467 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| July 21, 2021 Filed Jul 22, 2021 17:15 UTC |
Namkung James WChief Accounting Officer
|
SaleCommon Stock | 1,887 | $120.00 | $226,440.00 |
DisclosureSEC source: 0001209191-21-047807 · doc4.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,343 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2021. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,595 shares of common stock and 2,760 unvested restricted stock units ("RSUs"), and 4,988 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. Read SEC document |
| May 26, 2021 Filed May 28, 2021 16:32 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 52,582 | $0.00 Strike: $25.87 | $0.00 |
DisclosureSEC source: 0001209191-21-036548 · doc4.xml · derivative · entry 9 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,582 Underlying: Common Stock · 52,582 shares Expires 2023-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options are fully vested. Read SEC document |
| May 26, 2021 Filed May 28, 2021 16:32 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 36,955 | $0.00 Strike: $22.43 | $0.00 |
DisclosureSEC source: 0001209191-21-036548 · doc4.xml · derivative · entry 8 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,955 Underlying: Common Stock · 36,955 shares Expires 2022-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options are fully vested. Read SEC document |
| May 26, 2021 Filed May 28, 2021 16:32 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 26,715 | $113.40 | $3,029,379.48 |
DisclosureSEC source: 0001209191-21-036548 · doc4.xml · nonDerivative · entry 6 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,151,705 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F6 · price: The price range for the aggregate amount sold by the direct holder is $113.00 - $113.79. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F7 · balance_after: These shares are beneficially owned directly by Continental Power Exchange, Inc. ("CPEX"). Mr. Sprecher beneficially owns 100% of the equity interest in CPEX directly. Read SEC document |
| May 26, 2021 Filed May 28, 2021 16:32 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 33,285 | $112.55 | $3,746,103.60 |
DisclosureSEC source: 0001209191-21-036548 · doc4.xml · nonDerivative · entry 5 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,178,420 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F5 · price: The price range for the aggregate amount sold by the direct holder is $112.00 - $112.99. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 26, 2021 Filed May 28, 2021 16:32 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 50,837 | $113.37 | $5,763,568.62 |
DisclosureSEC source: 0001209191-21-036548 · doc4.xml · nonDerivative · entry 4 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,345,890 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $112.96 - $113.72. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,274,378 shares of common stock and 71,512 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| May 26, 2021 Filed May 28, 2021 16:32 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 58,200 | $112.54 | $6,549,635.94 |
DisclosureSEC source: 0001209191-21-036548 · doc4.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,396,727 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $111.96 - $112.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 26, 2021 Filed May 28, 2021 16:32 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 52,582 | $25.87 | $1,360,296.34 |
DisclosureSEC source: 0001209191-21-036548 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,454,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| May 26, 2021 Filed May 28, 2021 16:32 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 36,955 | $22.43 | $828,900.65 |
DisclosureSEC source: 0001209191-21-036548 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,402,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:31 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 500 | $113.48 | $56,739.00 |
DisclosureSEC source: 0001209191-21-036546 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,227 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $113.33 - $113.59. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 33,576 shares of common stock and 6,651 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:31 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 958 | $112.69 | $107,956.16 |
DisclosureSEC source: 0001209191-21-036546 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,727 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $112.33 - $113.27. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:35 UTC |
CRISP CHARLES RDirector
|
SaleCommon Stock | 5,932 | $112.44 | $667,003.57 |
DisclosureSEC source: 0001209191-21-034931 · doc4.xml · nonDerivative · entry 2 CRISP CHARLES R · CIK 0001015825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,602 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $112.08 - $112.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 36,881 shares of common stock and 1,721 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:35 UTC |
CRISP CHARLES RDirector
|
SaleCommon Stock | 1,697 | $111.76 | $189,656.72 |
DisclosureSEC source: 0001209191-21-034931 · doc4.xml · nonDerivative · entry 1 CRISP CHARLES R · CIK 0001015825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,534 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $111.05 - $112.04. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:36 UTC |
SPRIESER JUDITH ADirector
|
SaleCommon Stock | 500 | $112.51 | $56,253.00 |
DisclosureSEC source: 0001209191-21-034934 · doc4.xml · nonDerivative · entry 2 SPRIESER JUDITH A · CIK 0001206994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,326 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $112.22 - $112.69. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 27,385 shares of common stock and 1,941 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:36 UTC |
SPRIESER JUDITH ADirector
|
SaleCommon Stock | 390 | $111.75 | $43,582.19 |
DisclosureSEC source: 0001209191-21-034934 · doc4.xml · nonDerivative · entry 1 SPRIESER JUDITH A · CIK 0001206994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,826 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $111.05 - $112.03. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 19, 2021 Filed May 19, 2021 21:57 UTC |
Hague William JeffersonDirector
|
SaleCommon Stock | 675 | $110.00 | $74,250.00 |
DisclosureSEC source: 0001209191-21-034096 · doc4.xml · nonDerivative · entry 2 Hague William Jefferson · CIK 0001652762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,595 F2 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 12,654 shares of common stock and 1,941 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| May 17, 2021 Filed May 19, 2021 21:57 UTC |
Hague William JeffersonDirector
|
Tax withholdingCommon Stock | 147 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034096 · doc4.xml · nonDerivative · entry 1 Hague William Jefferson · CIK 0001652762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,270 F1 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:36 UTC |
CRISP CHARLES RDirector
|
GrantCommon Stock | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033508 · doc4.xml · nonDerivative · entry 1 CRISP CHARLES R · CIK 0001015825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,231 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 44,510 shares of common stock and 1,721 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:43 UTC |
NOONAN THOMAS EDirector
|
GrantCommon Stock | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033530 · doc4.xml · nonDerivative · entry 1 NOONAN THOMAS E · CIK 0001079742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,487 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 12,766 shares of common stock and 1,721 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:49 UTC |
TESE VINCENTDirector
|
GrantCommon Stock | 1,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033547 · doc4.xml · nonDerivative · entry 1 TESE VINCENT · CIK 0001042445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,691 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 1,941 restricted stock units awarded, 1,721 were awarded as compensation for service on the Issuer's board and 220 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 35,750 shares of common stock and 1,941 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| May 14, 2021 Filed May 18, 2021 16:44 UTC |
SALERNO FREDERIC VDirector
|
GrantCommon Stock | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033533 · doc4.xml · nonDerivative · entry 1 SALERNO FREDERIC V · CIK 0001180138 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,828 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 11,107 shares of common stock and 1,721 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:38 UTC |
Farooqui Duriya MDirector
|
GrantCommon Stock | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033516 · doc4.xml · nonDerivative · entry 1 Farooqui Duriya M · CIK 0001699994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,372 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 9,651 shares of common stock and 1,721 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:39 UTC |
Hague William JeffersonDirector
|
GrantCommon Stock | 1,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033520 · doc4.xml · nonDerivative · entry 1 Hague William Jefferson · CIK 0001652762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,417 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 1,941 restricted stock units awarded, 1,721 were awarded as compensation for service on the Issuer's board and 220 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Futures Europe. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 13,476 shares of common stock and 1,941 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:47 UTC |
SPRIESER JUDITH ADirector
|
GrantCommon Stock | 1,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033540 · doc4.xml · nonDerivative · entry 1 SPRIESER JUDITH A · CIK 0001206994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,216 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 1,941 restricted stock units awarded, 1,721 were awarded as compensation for service on the Issuer's board and 220 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 28,275 shares of common stock and 1,941 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:41 UTC |
Mulhern Mark FDirector
|
GrantCommon Stock | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033525 · doc4.xml · nonDerivative · entry 1 Mulhern Mark F · CIK 0001342425 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,414 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 represents unvested restricted stock units. The restricted stock units vest on the one-year anniversary of the date of grant. Of the 3,414 unvested restricted stock units, 1,693 will vest on December 4, 2021 and 1,721 will vest on May 14, 2022. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:45 UTC |
Silver Caroline LouiseDirector
|
GrantCommon Stock | 1,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033535 · doc4.xml · nonDerivative · entry 1 Silver Caroline Louise · CIK 0001821735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,041 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 1,941 restricted stock units awarded, 1,721 were awarded as compensation for service on the Issuer's board and 220 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Europe Limited. F2 · balance_after: The common stock number referred in Table 1 represents unvested restricted stock units. The restricted stock units vest on the one-year anniversary of the date of grant. Of the 4,041 unvested restricted stock units, 2,100 will vest on September 17, 2021 and 1,941 will vest on May 14, 2022. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:34 UTC |
Cooper Shantella E.Director
|
GrantCommon Stock | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033506 · doc4.xml · nonDerivative · entry 1 Cooper Shantella E. · CIK 0001698291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,414 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 represents unvested restricted stock units. The restricted stock units vest on the one-year anniversary of the date of grant. Of the 3,414 unvested restricted stock units, 1,693 will vest on December 4, 2021 and 1,721 will vest on May 14, 2022. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:32 UTC |
Bowen SharonDirector
|
GrantCommon Stock | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033503 · doc4.xml · nonDerivative · entry 1 Bowen Sharon · CIK 0001724974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,889 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 9,168 shares of common stock and 1,721 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| May 03, 2021 Filed May 5, 2021 16:43 UTC |
Namkung James WChief Accounting Officer
|
SaleCommon Stock | 1,828 | $117.77 | $215,283.56 |
DisclosureSEC source: 0001209191-21-030354 · doc4.xml · nonDerivative · entry 2 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,120 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 11,372 shares of common stock and 2,760 unvested restricted stock units ("RSUs"), and 4,988 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. Read SEC document |
| May 03, 2021 Filed May 5, 2021 16:43 UTC |
Namkung James WChief Accounting Officer
|
SaleCommon Stock | 149 | $117.77 | $17,547.58 |
DisclosureSEC source: 0001209191-21-030354 · doc4.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,948 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $117.61 - $117.77. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 20:34 UTC |
Martin Lynn CPresident, Fixed Income & Data
|
SaleCommon Stock | 2,500 | $120.00 | $300,000.00 |
DisclosureSEC source: 0001209191-21-028281 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, Fixed Income & Data 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,279 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 25,004 shares of common stock and 12,275 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| April 21, 2021 Filed Apr 21, 2021 20:31 UTC |
Hill Scott AChief Financial Officer
|
GiftCommon Stock | 3,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027791 · doc4.xml · nonDerivative · entry 6 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,452 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · shares: The transaction involved a gift of 3,435 shares of the Issuer's common stock by the reporting person to philanthropic organizations. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 119,168 shares of common stock and 22,284 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 20:31 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,492 | $0.00 Strike: $67.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027791 · doc4.xml · derivative · entry 9 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,433 Underlying: Common Stock · 1,492 shares Expires 2028-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 20:31 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 27,905 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-21-027791 · doc4.xml · derivative · entry 8 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,085 Underlying: Common Stock · 27,905 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.